This year is shaping up to be a strong one for dividend stocks. Payouts to shareholders are projected to reach $1.39 trillion for all of this year, just 3% shy of their 2019 pre-pandemic high, according to British asset manager Janus Henderson. Dividend payments in the second quarter of this year increased 26% from the
If you think Carnival (NYSE:CCL) and CCL stock is a good bet at almost $24, you might want to think again. Covid-19 is still very much still an “unwanted passenger” on its cruise ships. As a result, a resumption to pre-pandemic cruising — as well as improvements in the CCL stock price — seem like they’re
Is going long Palantir (NYSE:PLTR) stock a bet on the big data dynamo continuing to knock things out of the park? Or is it a bet that the “growth at any price” environment that the market continues to be in will stay intact? The answer is a little bit of Column A, but mostly Column
Gold has long been regarded as a safe haven in times of market turmoil. Many investors have gained exposure to the precious metal by buying stocks of companies engaged in exploration and mining. Some of the major players in the gold industry include Canada-based Franco Nevada Corp. (FNV), Newmont Corp. (NEM), and Australia-based Newcrest Mining Ltd. (NCM).
In this video, we cover the top 5 option strategies for monthly income for option traders. This video will give you an overview if you just started trading options. You will see examples of various option strategies like selling a covered call or upside calls that you can do with any stock or ETF which
Advanced Micro Devices (NASDAQ:AMD) stock is up 18% so far in 2021. If anything, AMD stock is now cheaper than it was before. Source: JHVEPhoto / Shutterstock.com That’s because AMD continues to grow rapidly on both the top and bottom lines. Advanced Micro Devices saw $710 million of net income in its second quarter, or
Thomas Montag Source: Bank of America Two trusted deputies of Bank of America CEO Brian Moynihan will depart at the end of the year, setting up a succession race among the company’s top managers. Tom Montag, 64, who is chief operating officer and leads the global banking and markets division, as well as Anne Finucane,
Roberto Machado Noa Check out the companies making headlines after the bell: Peloton Interactive — Shares of Peloton sunk about 10% in extended trading after the exercise equipment company reported a wider-than-expected quarterly loss. The company posted a loss of $1.05 per share in the fiscal fourth quarter, compared with a loss of 45 cents
Investors have so many different choices in the market today that it can be difficult to know which is the best route for one’s capital. However, we believe that the best path to compounding wealth — and securing financial freedom — is through prudent, long-term allocation to dividend stocks. Even still, the types of dividend
This is my first time writing about Novavax (NASDAQ:NVAX) and the more I learn about the company, I can’t help but think about Inception, the Leonardo DiCaprio movie about dreams within dreams. A lot of the discussion around Novavax’s Covid-19 vaccine feels like living in that film’s impossible dream worlds. People buying NVAX stock are believing
The shining momentum for ContextLogic (NASDAQ:WISH) came and left in a hurry in June. Meme traders, where traders depicted stock buys with an image and a few words, lifted WISH stock. After ContextLogic posted results on August 12, any positive momentum all but evaporated. That is bad news for speculators, who thrive on trading volume.
Coffee stocks have had a rough go of it recently. The coffee industry was one of the sectors that were hit hard due to the pandemic-induced slowdown. According to National Coffee Association (NCA) survey, the first few weeks of the lockdown saw a healthy increase in coffee sales. However, sales took a significant dip in
A rendering of the Series2 cargo lunar lander on the moon’s surface. ispace Japanese lunar exploration start-up ispace unveiled the next-generation of its cargo lander, under development by its U.S. subsidiary in Colorado. “We saw the growing demand for payloads to the lunar surface. NASA’s Artemis program was a big part of this, but we’re
In this article CRM ANF SJM DG DLTR COTY Check out the companies making headlines before the bell: Coty (COTY) – The cosmetics maker’s shares added 2.7% in the premarket after it said it expects a return to annual sales growth this year. Coty’s adjusted loss for its latest quarter was 9 cents per share,
This is no longer our grandparents’ or even parents’ stock market. High valuations have become the norm in an investing world dominated by retail traders. But when market volatility is high and economic uncertainty is on the rise, your best bet is to invest in mega-cap stocks. Why? Well, although there are no guarantees in
Tilray (NASDAQ:TLRY) stock has become one of the biggest cannabis names following the Aphria-Tilray business combination. Source: Jarretera / Shutterstock.com The newly combined company now has a much greater chance at carving out a piece of the U.S. market following the deal. But the company is also currently making headlines in regard to other deal
One of the best things about being a hypergrowth investor is that I get to constantly study the world of tomorrow. In so doing, I’m always uncovering exciting new investment trends oozing with potential. And just last week, I uncovered a booming tech industry that I’m willing to bet you’ve never heard of before. Yet,
The industrial sector includes companies that produce machinery, equipment, and supplies that are used in construction and manufacturing, as well as those that provide related services. These companies are closely tied to the economy, and their business volume often falls sharply during recessions, though each industrial subsector often performs differently. Well-known companies include Lockheed Martin
Increasing M&A deals and cutting edge therapies are driving biotech ETFs higher. IShares Nasdaq Biotechnology ETF: https://www.zacks.com/funds/etf/IBB/profile?cid=CS-YOUTUBE-FT-VID SPDR S&P Biotech ETF: https://www.zacks.com/funds/etf/XBI/profile?cid=CS-YOUTUBE-FT-VID ARK Genomic Revolution ETF: https://www.zacks.com/funds/etf/ARKG/profile?cid=CS-YOUTUBE-FT-VID Virtus LifeSci Biotech Clinical Trials ETF: https://www.zacks.com/funds/etf/BBC/profile?cid=CS-YOUTUBE-FT-VID ALPS Medical Breakthroughs ETF: https://www.zacks.com/funds/etf/SBIO/profile?cid=CS-YOUTUBE-FT-VID Merck: https://www.zacks.com/stock/quote/MRK?cid=CS-YOUTUBE-FT-VID Biogen: https://www.zacks.com/stock/quote/BIIB?cid=CS-YOUTUBE-FT-VID Sanofi: https://www.zacks.com/stock/quote/SNY?cid=CS-YOUTUBE-FT-VID ArQule: https://www.zacks.com/stock/quote/ARQL?cid=CS-YOUTUBE-FT-VID Synthorx: https://www.zacks.com/stock/quote/THOR?cid=CS-YOUTUBE-FT-VID Follow us on StockTwits: http://stocktwits.com/ZacksResearch Follow